Baker Brothers Life Sciences LP

Director, 10% OwnerKodiak Sciences Inc. (KOD) · full profile →Form 4 · filed Dec 19, 2025
Net Buying
Open-Market Buys
$60.0M
Open-Market Sells
$0
Net Open-Market Flow
$60.0M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 18, 2025Buy(P)217K$23.00$5.0M1.6M
Dec 18, 2025Buy(P)2.4M$23.00$55.0M18.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-326820) within minutes of acceptance. Every field above traces to the original document. Verify it directly: